In addition to measuring ASCL-1 protein levels, we assessed the changes in expression of other genes in BON, MZ-CRC-1 and H727 cells after treatment with increasing doses of DHN-II-84 or DHN-III-14. The gene discussed is ASCL1; the disease is colorectal carcinoma.